As of March 31, 2026, DIAGNOS inc. carries a market capitalization of 33.11M, placing it among publicly traded companies globally. Its enterprise value stands at 32.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 33.11M |
| Enterprise Value | 32.59M |
DIAGNOS inc.'s next confirmed earnings release is scheduled for December 1, 2026.
| Earnings Date | 12/1/2026 |
As of March 31, 2026, DIAGNOS inc. has 120.41M shares outstanding.
| Shares Outstanding | 120.41M |
These figures are as of March 31, 2026. The price-to-sales ratio is 464.02, and the price-to-book ratio stands at 48.21.
| PS Ratio | 464.02 |
| PB Ratio | 48.21 |
| P/TBV Ratio | 48.21 |
| P/FCF Ratio | -8.07 |
| P/OCF Ratio | -8.09 |
These figures are as of March 31, 2026. The EV/Sales ratio of 497.70 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 32.59M versus a market cap of 33.11M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 497.70 |
As of March 31, 2026, DIAGNOS inc. maintains a current ratio of 1.49, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 204.05, indicating elevated leverage, while an interest coverage ratio of -10.55 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.49 |
| Quick Ratio | 1.44 |
| Debt / Equity | 204.05 |
| Debt / EBITDA | -0.34 |
| Interest Coverage | -10.55 |
Over the twelve months ended March 31, 2026, DIAGNOS inc. posted a negative return on equity (ROE) of -990.25, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -151.17, reflecting losses generated across the asset base.
| Return on Equity (ROE) | -990.25 |
| Return on Assets (ROA) | -151.17 |
As of the close on November 16, 2026, DIAGNOS inc.'s stock has gained approximately 8.62% over the past 52 weeks. The 50-day moving average sits at 0.42, while the 200-day moving average is 0.31.
| 52-Week Price Change | 8.62% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.31 |
Over the twelve months ended March 31, 2026, DIAGNOS inc. generated 65,478.00 in revenue and converted that into -4.56M in net income, yielding earnings per share of -0.04. EBITDA reached -4.10M, while operating income came in at -4.23M.
| Revenue | 65,478.00 |
| Gross Profit | 10,014.00 |
| Operating Income | -4.23M |
| Pretax Income | -4.56M |
| Net Income | -4.56M |
| EBITDA | -4.10M |
| EBIT | -4.23M |
| Earnings Per Share (EPS) | -0.04 |
As of March 31, 2026, DIAGNOS inc. holds 1.93M in cash and equivalents against 1.40M in total debt, resulting in a net debt position of 901,219.00. Total book value stands at 686,897.00, with working capital of 722,233.00 providing operational flexibility.
| Cash & Cash Equivalents | 1.93M |
| Total Debt | 1.40M |
| Net Debt | 901,219.00 |
| Equity (Book Value) | 686,897.00 |
| Book Value Per Share | 0.01 |
| Working Capital | 722,233.00 |
DIAGNOS inc. produced -3.75M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -11,061.00 in capital expenditures, free cash flow totaled -3.76M - equivalent to -0.03 per share.
| Operating Cash Flow | -3.75M |
| Capital Expenditures | -11,061.00 |
| Free Cash Flow | -3.76M |
| FCF Per Share | -0.03 |
Over the twelve months ended March 31, 2026, DIAGNOS inc. posted a gross margin of 15.29, reflecting its pricing power and cost economics. The operating margin of -6,459.65 and net profit margin of -6,956.84 provide insight into operational efficiency.
| Gross Margin | 15.29 |
| Operating Margin | -6,459.65 |
| Pretax Margin | -6,956.84 |
| Profit Margin | -6,956.84 |
| EBITDA Margin | -6,261.93 |
Over the twelve months ended March 31, 2026, DIAGNOS inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -12.39: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -7.28, meaning DIAGNOS inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -7.28 |
| FCF Yield | -12.39 |
DIAGNOS inc.'s most recent stock split took place on April 24, 2019 with a 10:1 split ratio.
| Last Split Date | 4/24/2019 |
| Split Ratio | 10:1 |
As of March 31, 2026, DIAGNOS inc. has an Altman Z-Score of -28.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -28.63 |
Already premium?